CORC  > 中国医学科学院 北京协和医学院
CD19 targeted chimeric antigen receptor T (CAR-T) cell immunotherapy has demonstrated significant anti-leukemia activity in pediatric patients with relapsed/refractory acute lymphocytic leukemia: A multicentre study in China.
Xiao, Lei; Tang, Yongmin; Zhu, Xiaofan; Chen, Jing; Wu, Zhao
2017
会议名称JOURNAL OF CLINICAL ONCOLOGY
会议日期2017-05-20
收录类别CPCI-S
URL标识查看原文
内容类型会议论文
URI标识http://www.corc.org.cn/handle/1471x/6369598
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Xiao, Lei,Tang, Yongmin,Zhu, Xiaofan,et al. CD19 targeted chimeric antigen receptor T (CAR-T) cell immunotherapy has demonstrated significant anti-leukemia activity in pediatric patients with relapsed/refractory acute lymphocytic leukemia: A multicentre study in China.[C]. 见:JOURNAL OF CLINICAL ONCOLOGY. 2017-05-20.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace